Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,565Revenue (TTM) $M71.5Net Margin (%)-265.2Altman Z-Score-3.3
Enterprise Value $M3,633EPS (TTM) $-0.8Operating Margin %-198.2Piotroski F-Score6
P/E(ttm)--Beneish M-Score-2.9Pre-tax Margin (%)-265.2Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio1.8Cash flow > EarningsY
Price/Sales48.75-y EBITDA Growth Rate %--Current Ratio1.8Lower Leverage y-yY
Price/Free Cash Flow66.7y-y EBITDA Growth Rate %--ROA % (ttm)-49.5Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M230ROIC % (ttm)-617.3Gross Margin Increase y-yY

Gurus Latest Trades with EXEL

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
EXELJoel Greenblatt 2016-06-30 Buy $4 - $7.85
($5.74)
$ 15.48170%New holding21,735
EXELCharles Brandes 2016-03-31 Sold Out $3.64 - $5.64
($4.25)
$ 15.48264%Sold Out0
EXELCharles Brandes 2015-12-31 Reduce$4.79 - $6.33
($5.59)
$ 15.48177%Reduce -44.88%14,000
EXELCharles Brandes 2015-06-30 Buy $2.57 - $4.03
($3.24)
$ 15.48378%New holding25,400
EXELFirst Eagle Investment 2014-06-30 Sold Out -0.0038%$3.22 - $3.8
($3.45)
$ 15.48349%Sold Out0
EXELFirst Eagle Investment 2014-03-31 Reduce-0.01%$3.38 - $8.24
($6.84)
$ 15.48126%Reduce -65.91%400,000
EXELFirst Eagle Investment 2012-09-30 Add0.02%$4.28 - $6.45
($5.29)
$ 15.48193%Add 422.58%1,175,800
EXELFirst Eagle Investment 2012-03-31 Add$4.49 - $6.47
($5.14)
$ 15.48201%Add 125.00%225,000
EXELFirst Eagle Investment 2011-12-31 Buy $3.95 - $7.81
($5.01)
$ 15.48209%New holding100,000
EXELCarl Icahn 2011-09-30 Sold Out -0.43%$5.5 - $9.22
($7.34)
$ 15.48111%Sold Out0
EXELFirst Eagle Investment 2011-03-31 Sold Out -0.01%$7.22 - $12.45
($9.95)
$ 15.4856%Sold Out0
EXELFirst Eagle Investment 2010-12-31 Buy 0.01%$3.98 - $9.08
($5.66)
$ 15.48173%New holding280,000
EXELFirst Eagle Investment 2009-12-31 Sold Out -0.02%$5.33 - $8
($6.84)
$ 15.48126%Sold Out0
EXELFirst Eagle Investment 2009-09-30 Buy 0.02%$4.4 - $6.99
($5.65)
$ 15.48174%New holding274,700
EXELFirst Eagle Investment 2009-06-30 Sold Out -0.01%$4.16 - $5.55
($4.87)
$ 15.48218%Sold Out0
EXELFirst Eagle Investment 2009-03-31 Reduce$4.32 - $5.85
($4.8)
$ 15.48223%Reduce -25.67%144,800
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

EXEL is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


EXEL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Schwab GiselaPres Prod Dev & Med Aff & CMO 2016-08-31Sell131,155$10.9840.98view
Schwab GiselaPres Prod Dev & Med Aff & CMO 2016-08-04Sell42,338$1140.73view
WILLSEY LANCEDirector 2016-05-11Buy60,000$4.97211.47view
WILLSEY LANCEDirector 2015-12-11Buy100,000$4.89216.56view
Lamb PeterEVP, Discovery Research & CSO 2015-10-16Sell51,549$5.8166.9view
Lamb PeterEVP, Discovery Research & CSO 2015-10-13Sell300,876$5.84165.07view
MARCHESI VINCENT TDirector 2014-09-17Buy20,000$1.71805.26view
WILLSEY LANCEDirector 2013-08-29Buy10,000$5.15200.58view
MARCHESI VINCENT TDirector 2012-12-20Buy4,000$4.68230.77view
MARCHESI VINCENT TDirector 2012-12-19Buy6,000$4.72227.97view

Quarterly/Annual Reports about EXEL:

News about EXEL:

Articles On GuruFocus.com
The Best-Performing Non-S&P Stocks of 2015 Dec 30 2015 
5-year lows: Synta Pharmaceuticals Inc, Exelixis Inc, Entropic Communications Inc, and Aeropostale I Dec 28 2014 
5-year lows: National Presto Industries, Ennis Inc, Landauer Inc, and Exelixis Inc. Sep 28 2014 
Weekly 3-Year Low Highlights: UAN, CLD, EXEL, QNST Sep 06 2014 
Five-Year Lows: Rentech Nitrogen Partners LP, SandRidge Permian Trust, Millennial Media Inc., Exelix May 05 2014 
5 Resilient Biotech Stocks to Buy for 2012 Feb 28 2012 
Exelixis Inc. Reports Operating Results (10-K) Feb 22 2011 
Exelixis Inc. (EXEL) CFO Frank Karbe buys 16,500 Shares Aug 25 2010 
Exelixis Inc. Reports Operating Results (10-Q) Aug 05 2010 
Exelixis Inc. Reports Operating Results (10-Q) May 11 2010 

More From Other Websites
EXELIXIS, INC. Files SEC form 8-K, Change in Directors or Principal Officers Sep 26 2016
4 Biopharma Companies Moving on Monday Ahead of the Presidential Debate Sep 26 2016
Surging Earnings Estimates Signal Good News for Exelixis (EXEL) Sep 26 2016
Exelixis Elects Julie Anne Smith to Its Board of Directors Sep 26 2016
Exelixis Announces Collaborator Daiichi Sankyo’s Initiation of Phase 3 Clinical Development for... Sep 26 2016
6:11 am Exelixis announces its partner Daiichi Sankyo (DSNKY)... Sep 26 2016
Exelixis Elects Julie Anne Smith to Its Board of Directors Sep 26 2016
Exelixis Announces Collaborator Daiichi Sankyo’s Initiation of Phase 3 Clinical Development for... Sep 26 2016
Exelixis Announces Collaborator Daiichi Sankyo’s Initiation of Phase 3 Clinical Development for... Sep 26 2016
Exelixis Provides Update on Timing of Key Cabozantinib Clinical Data Presentation at the ESMO 2016... Sep 20 2016
3 Reasons Momentum Stock Investors Will Love Exelixis (EXEL) Sep 20 2016
Will Exelixis (EXEL) Continue to Surge Higher? Sep 15 2016
Exelixis Wins EU Approval for Cabometyx RCC Treatment (EXEL) Sep 14 2016
Bevy Of Biotech Stocks Healthy; Sarepta, Bluebird, Exelixis Soar Sep 14 2016
Bevy Of Biotech Stocks Healthy; Sarepta, Bluebird, Exelixis Soar Sep 14 2016
Exelixis (EXEL) Stock Advances, EC Approves Kidney Cancer Drug Sep 14 2016
4 stocks to watch Sep 14 2016
Key FDA Decisions and Trial Results Coming in the Next 2 Months Sep 14 2016
European Commission Approves CABOMETYX™ (cabozantinib) Tablets for the Treatment of Advanced Renal... Sep 14 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)